Page last updated: 2024-08-25

clarithromycin and Cancer of Skin

clarithromycin has been researched along with Cancer of Skin in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (16.67)	18.2507
2000's	3 (25.00)	29.6817
2010's	6 (50.00)	24.3611
2020's	1 (8.33)	2.80

Authors

Authors	Studies
Bokotas, C; Chasapi, V; Gregoriou, S; Kontochristopoulos, G; Plaka, M; Polydorou, D; Rigopoulos, D; Stratigos, A	1
Gota, V; Mehta, M; Patel, K; Patil, A; Vavia, P	1
Donadoni, G; Ferreri, AJ; Govi, S; Kiesewetter, B; Raderer, M; Sassone, M; Scarfò, L	1
Cerroni, L; João, A; Ponte, P; Serrão, V; Vale, E; Viana, I	1
Cabras, A; Carbone, A; Devizzi, L; Gianni, AM; Mirabile, A	1
Bargiacchi, O; Brondolo, R; Brustia, D; Garavelli, PL; Rizzo, G; Salerno, AM	1
Abbey, BV; Jakubovic, HR; Lai, J	1
Athanasiou, E; Delli, FS; Kountouras, I; Kountouras, J; Mandekou-Lefaki, I; Mattheou-Vakali, G	1
McKenna, KE; Morris, TC; Ramadan, KM	1
Johnson, TM; Lowe, L; Peters, NT; Saluja, A	1
Aoki, S; Fukuno, Y; Hayashi, S; Kawashima, M; Nagata, M; Taniguchi, S; Tominaga, M; Tsuruta, N; Yatsunami, J	1
De'Ambrosis, BJ; Ozluer, SM	1

Trials

1 trial(s) available for clarithromycin and Cancer of Skin

Article	Year
High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Breast Neoplasms; Clarithromycin; Colorectal Neoplasms; Disease-Free Survival; Eye Neoplasms; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Multiple Primary; Salvage Therapy; Skin Neoplasms; Stomach Neoplasms	2015

Article

Year

High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial.

Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8

Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Breast Neoplasms; Clarithromycin; Colorectal Neoplasms; Disease-Free Survival; Eye Neoplasms; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Multiple Primary; Salvage Therapy; Skin Neoplasms; Stomach Neoplasms

2015

Other Studies

11 other study(ies) available for clarithromycin and Cancer of Skin

Article	Year
Herpetic whitlow mimicking squamous cell carcinoma in an immunocompromised patient. Journal of the European Academy of Dermatology and Venereology : JEADV, 2020, Volume: 34, Issue:2 Topics: Anti-Bacterial Agents; Antiviral Agents; Carcinoma, Squamous Cell; Clarithromycin; Diagnosis, Differential; Fingers; Herpes Simplex; Humans; Male; Middle Aged; Skin Neoplasms; Staphylococcus aureus; Valacyclovir	2020
Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity. International journal of pharmaceutics, 2014, Sep-10, Volume: 472, Issue:1-2 Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chickens; Clarithromycin; Cyclosporine; Cytochrome P-450 CYP3A Inhibitors; Drug Compounding; Gastrointestinal Tract; Hypromellose Derivatives; Ileum; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Particle Size; Rats, Sprague-Dawley; Skin Neoplasms; Surface Properties; Tumor Burden	2014
Borderline CD30+ cutaneous lymphoproliferative disorder: report of a case with expression of cytotoxic markers and response to clarithromycin. Journal of cutaneous pathology, 2011, Volume: 38, Issue:3 Topics: Anti-Inflammatory Agents; Biomarkers, Tumor; Clarithromycin; Humans; Ki-1 Antigen; Lymphoma, T-Cell, Cutaneous; Male; Skin Neoplasms; Young Adult	2011
MALT lymphoma and Kaposi sarcoma in an HIV-negative patient. American journal of hematology, 2010, Volume: 85, Issue:10 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clarithromycin; Cyclophosphamide; Gastritis; Helicobacter Infections; Helicobacter pylori; Herpesvirus 8, Human; HIV Seronegativity; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasms, Second Primary; Prednisone; Proton Pump Inhibitors; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Stomach Neoplasms; Stomach Ulcer; Vinblastine; Vincristine	2010
[Whipple's disease in an AIDS patient with Kaposi's sarcoma. Report of a case]. Le infezioni in medicina, 2010, Volume: 18, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Clarithromycin; Duodenum; Humans; Male; Sarcoma, Kaposi; Skin Neoplasms; Tropheryma; Whipple Disease	2010
Epithelioid histiocytic infiltrate caused by Mycobacterium scrofulaceum infection: a potential mimic of various neoplastic entities. The American Journal of dermatopathology, 2013, Volume: 35, Issue:2 Topics: Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Female; Histiocytosis; Humans; Immunocompromised Host; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium scrofulaceum; Prednisone; Skin Diseases, Bacterial; Skin Neoplasms	2013
Primary cutaneous MALT-type lymphoma and Helicobacter pylori: a possible relationship. Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:5 Topics: Adult; Amoxicillin; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole; Skin Neoplasms	2006
Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma. The Lancet. Oncology, 2006, Volume: 7, Issue:11 Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Clarithromycin; Dexamethasone; Diphosphonates; Glomerulonephritis; Humans; Idarubicin; Imidazoles; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Pamidronate; Protein Synthesis Inhibitors; Pyrazines; Skin Neoplasms; Thalidomide; Zoledronic Acid	2006
A surgical wound infection due to Mycobacterium chelonae successfully treated with clarithromycin. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 1997, Volume: 23, Issue:7 Topics: Aged; Anti-Bacterial Agents; Carcinoma, Basal Cell; Clarithromycin; Female; Humans; Leg; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Neoplasms; Surgical Wound Infection	1997
Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells. Cancer letters, 1999, Dec-01, Volume: 147, Issue:1-2 Topics: Animals; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cisplatin; Clarithromycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Roxithromycin; Skin Neoplasms; Tumor Cells, Cultured; Vindesine	1999
Mycobacterium abscessus wound infection. The Australasian journal of dermatology, 2001, Volume: 42, Issue:1 Topics: Anti-Bacterial Agents; Carcinoma, Squamous Cell; Clarithromycin; Foot; Humans; Leg; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Postoperative Complications; Skin Neoplasms; Surgical Wound Infection	2001